title: Paraneoplastic immune-mediated neurological effects of systemic cancers.
abstract: Cancer patients may develop paraneoplastic neurological conditions associated with autoantibodies directed against neural or neuromuscular tissues. These syndromes are frequently manifested in advance of the cancer presentation by several months or years necessitating a detailed and expensive investigation to search for the presence of a malignancy. In such cases additional assistance may be obtained by the early employment of whole body 18F flurodeoxyglucose positron emission tomography as a cancer screening imaging procedure for early cancer diagnosis and potential therapy. Effective therapy of the primary cancer consists the best current therapy for a given paraneoplastic syndrome. However, other forms of immune modulation, such as plasma exchange, intravenous gamma globulin, other immune therapies and symptomatic treatment for certain PNS may have additional benefit.
authors.affiliation: Neurosurgical Research Institute, University of Ioannina, Ioannina, Greece.
authors.forename: Chrissa
authors.initials: C
authors.lastname: Sioka
authors.forename: Andreas
authors.initials: A
authors.lastname: Fotopoulos
authors.forename: Athanassios P
authors.initials: AP
authors.lastname: Kyritsis
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D049268:Positron-Emission Tomography / Q000379:methods; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D001323:Autoantibodies; D019788:Fluorodeoxyglucose F18